South African Tuberculosis Vaccine Initiative (SATVI)
Dr Elisa Nemes completed her PhD in HIV-specific T-cell immunology in Italy and France in 2008. She then worked on paediatric immune responses to HIV and TB in Cameroon. Dr Nemes joined the South African Tuberculosis Vaccine Initiative (SATVI) at the University of Cape Town in 2011. She is involved in clinical trials of new tuberculosis vaccines, development of immunodiagnostics and basic immunological studies on adaptive and innate immunity to M. Tb in children, adolescents, and adults. Her research focuses on identifying immune correlates of protection from M.tb infection and TB disease, which can facilitate development and assessment of new vaccines.